Phase I Study of Lapatinib (GW572016) in Combination With Weekly Ixabepilone (BMS 247550) in Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 27 Mar 2012
At a glance
- Drugs Lapatinib (Primary) ; Ixabepilone
- Indications Solid tumours
- Focus Adverse reactions
- 27 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 27 Mar 2012 Actual patients number (5) added as reported by ClinicalTrials.gov.
- 27 Mar 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.